A carregar...
Does anti-reflux surgery disrupt the pathway of Barrett’s esophagus progression to cancer?
In patients with Barrett’s esophagus (BE), anti-reflux surgery aims to sustainable control reflux symptoms and heal reflux induced esophageal mucosal inflammation and prevent progression of BE to adenocarcinoma. There is growing evidence that beside gastric acid, bile salts in refluxed duodenal juic...
Na minha lista:
| Publicado no: | Transl Gastroenterol Hepatol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327172/ https://ncbi.nlm.nih.gov/pubmed/30701208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2018.11.07 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|